Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
American Journal of Human Genetics|February 1, 1994
Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3W Vermeulen, R J Scott, S Rodgers, et al.
Cancer Research|February 1, 1993
Hypersensitivity of human lymphocytes to UV-B and solar irradiationC F Arlett, J E Lowe, S A Harcourt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1997
Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription geneE M Taylor, B C Broughton, E Botta, et al.
Cancer Research|October 23, 1997
A DNA double-strand break defective fibroblast cell line (180BR) derived from a radiosensitive patient represents a new mutant phenotypeC Badie, M Goodhardt, A Waugh, et al.
The British Journal of Radiology|May 23, 2006
Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosumC F Arlett, P N Plowman, P B Rogers, et al.
International Journal of Radiation Biology|March 1, 1991
Comparative human cellular radiosensitivity: III. Gamma-radiation survival of cultured skin fibroblasts and resting T-lymphocytes from the peripheral blood of the same individualM H Green, C F Arlett, J Cole, et al.
Cell Host & Microbe|November 20, 2012
Uncovering common principles in protein export of malaria parasitesChristof Grüring, Arlett Heiber, Florian Kruse, et al.
Journal of Medical Genetics|October 3, 2009
A novel splice variant of the DNA-PKcs gene is associated with clinical and cellular radiosensitivity in a patient with xeroderma pigmentosumFatemeh Abbaszadeh, Peter H Clingen, Colin F Arlett, et al.
Pharmacoepidemiology and Drug Safety|September 5, 2024
Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming CodeJohn Tazare, Shirley V Wang, Rosa Gini, et al.
Clinical Pharmacology and Therapeutics|September 16, 2014
Risk management plans as a tool for proactive pharmacovigilance: a cohort study of newly approved drugs in EuropeN S Vermeer, R G Duijnhoven, S M J M Straus, et al.
Pageof 23